Suchergebnisse - "Daver, Naval"

PubPharm (636)

51

Single-cell chromatin accessibility profiling of acute myeloid leukemia reveals heterogeneous lineage composition upon therapy-resistance

enthalten in: Communications biology | 2023

von Fan, H. | Wang, F. | Zeng, A. | +16

52

Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS) : Proceedings from the 1st International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)

enthalten in: Blood reviews | 2023

von Bewersdorf, J. | Xie, Z. | Bejar, R. | +39

53

Undetectable measurable residual disease is associated with improved outcomes in AML irrespective of treatment intensity

enthalten in: Blood advances | 2023

von Bazinet, A. | Kadia, T. | Short, N. | +24

54

A phase 1/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethylating agents

enthalten in: Journal of hematology & oncology | 2023

von Short, N. | Muftuoglu, M. | Ong, F. | +24

55

A phase 1/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethylating agents

enthalten in: Journal of hematology & oncology | 2023

von Short, N. | Muftuoglu, M. | Ong, F. | +24

56

A phase 1/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethylating agents

enthalten in: Journal of hematology & oncology | 2023

von Short, N. | Muftuoglu, M. | Ong, F. | +24

57

A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in IDH1-Mutated Myeloid Malignancies

enthalten in: Blood cancer discovery | 2023

von Lachowiez, C. | Loghavi, S. | Zeng, Z. | +24

58

Causal linkage of presence of mutant NPM1 to efficacy of novel therapeutic agents against AML cells with mutant NPM1

enthalten in: Leukemia | 2023

von Mill, C. | Fiskus, W. | Das, K. | +13

59

A Phase I study of Milademetan (DS3032b) in combination with low dose cytarabine with or without venetoclax in acute myeloid leukemia : Clinical safety, efficacy, and correlative analysis

enthalten in: Blood cancer journal | 2023

von Senapati, J. | Muftuoglu, M. | Ishizawa, J. | +21

60

An agenda to advance research in myelodysplastic syndromes : a TOP 10 priority list from the first international workshop in MDS

enthalten in: Blood advances | 2023

von Stahl, M. | Abdel-Wahab, O. | Wei, A. | +47